Phase II study of pembrolizumab in combination with cisplatin or carboplatin and pemetrexed as induction chemoimmunotherapy in resectable epithelioid and biphasic pleural mesothelioma (CHIMERA study).

Category Primary study
ConferenceASCO MEETING ABSTRACTS
Year 2025
This article has no abstract
Epistemonikos ID: e199f4af6746fa8bf903cef8ab23769455d9605e
First added on: Apr 25, 2026